Arielle W Tolman
Overview
Explore the profile of Arielle W Tolman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
457
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mitnick C, White R, Lu C, Rodriguez C, Bayona J, Becerra M, et al.
Eur Respir J
. 2016 Sep;
48(4):1160-1170.
PMID: 27587552
Debate persists about monitoring method (culture or smear) and interval (monthly or less frequently) during treatment for multidrug-resistant tuberculosis (MDR-TB). We analysed existing data and estimated the effect of monitoring...
2.
Shah N, Yuen C, Heo M, Tolman A, Becerra M
Clin Infect Dis
. 2015 Sep;
62(2):267-8.
PMID: 26400992
No abstract available.
3.
Chiang S, Khan F, Milstein M, Tolman A, Benedetti A, Starke J, et al.
Lancet Infect Dis
. 2014 Aug;
14(10):947-57.
PMID: 25108337
Background: Tuberculous meningitis disproportionately affects young children. We aimed to characterise treatment outcomes for this deadliest and most debilitating form of tuberculosis. Methods: We did a systematic review and meta-analysis...
4.
Jenkins H, Tolman A, Yuen C, Parr J, Keshavjee S, Perez-Velez C, et al.
Lancet
. 2014 Mar;
383(9928):1572-9.
PMID: 24671080
Background: Multidrug-resistant tuberculosis threatens to reverse recent reductions in global tuberculosis incidence. Although children younger than 15 years constitute more than 25% of the worldwide population, the global incidence of...
5.
Shah N, Yuen C, Heo M, Tolman A, Becerra M
Clin Infect Dis
. 2013 Sep;
58(3):381-91.
PMID: 24065336
Contact investigations among individuals living with drug-susceptible tuberculosis patients (source cases) have shown a high yield of tuberculosis disease and latent tuberculosis, but the yield of such investigations in households...
6.
Mitnick C, Franke M, Rich M, Alcantara Viru F, Appleton S, Atwood S, et al.
PLoS One
. 2013 Mar;
8(3):e58664.
PMID: 23516529
Rationale: A better understanding of the composition of optimal treatment regimens for multidrug-resistant tuberculosis (MDR-TB) is essential for expanding universal access to effective treatment and for developing new therapies for...
7.
Yuen C, Tolman A, Cohen T, Parr J, Keshavjee S, Becerra M
Pediatr Infect Dis J
. 2013 Jan;
32(5):e217-26.
PMID: 23348808
Background: Isoniazid resistance is an obstacle to the treatment of tuberculosis disease and latent tuberculosis infection in children. We aim to summarize the literature describing the risk of isoniazid-resistant tuberculosis...
8.
Tolman A, Kurtz M
Schizophr Bull
. 2010 Jul;
38(2):304-15.
PMID: 20624752
Quality of life (QOL) has been recognized as a crucial domain of outcome in schizophrenia treatment, and yet its determinants are not well understood. Recent meta-analyses suggest that symptoms have...